1 Matching Annotations
  1. Aug 2020
  2. www.nber.org www.nber.org
    Firm-level Exposure to Epidemic Diseases: Covid-19, SARS, and H1N1
    1
    1. Marlene_Wulf 06 Aug 2020

      Hassan, T. A., Hollander, S., van Lent, L., & Tahoun, A. (2020). Firm-level Exposure to Epidemic Diseases: Covid-19, SARS, and H1N1 (Working Paper No. 26971; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w26971

      is:preprint lang:en exposure COVID-19 epidemic diseases cost benefit risk firm gain loss disruption supply chain finance market response
    Visit annotations in context

    Tags

    Annotators

    URL

    nber.org/papers/w26971